CN106858595A - 一种烧伤专用型临床营养配方及其制备方法 - Google Patents
一种烧伤专用型临床营养配方及其制备方法 Download PDFInfo
- Publication number
- CN106858595A CN106858595A CN201710197736.6A CN201710197736A CN106858595A CN 106858595 A CN106858595 A CN 106858595A CN 201710197736 A CN201710197736 A CN 201710197736A CN 106858595 A CN106858595 A CN 106858595A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- powder
- drinking
- burn
- integration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 49
- 230000035764 nutrition Effects 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 238000009472 formulation Methods 0.000 title abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 90
- 229940088594 vitamin Drugs 0.000 claims abstract description 54
- 229930003231 vitamin Natural products 0.000 claims abstract description 54
- 235000013343 vitamin Nutrition 0.000 claims abstract description 54
- 239000011782 vitamin Substances 0.000 claims abstract description 54
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 54
- 239000000203 mixture Substances 0.000 claims abstract description 45
- 230000035622 drinking Effects 0.000 claims abstract description 31
- 235000008216 herbs Nutrition 0.000 claims abstract description 31
- 230000010354 integration Effects 0.000 claims abstract description 31
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 28
- 235000013305 food Nutrition 0.000 claims abstract description 26
- 235000015097 nutrients Nutrition 0.000 claims abstract description 26
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 22
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 22
- 150000001413 amino acids Chemical class 0.000 claims abstract description 20
- 235000012054 meals Nutrition 0.000 claims abstract description 20
- 241000196324 Embryophyta Species 0.000 claims abstract description 19
- 150000001875 compounds Chemical class 0.000 claims abstract description 19
- 239000002773 nucleotide Substances 0.000 claims abstract description 17
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 17
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000011573 trace mineral Substances 0.000 claims abstract description 16
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 16
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 14
- 235000006264 Asimina triloba Nutrition 0.000 claims abstract description 13
- 235000009467 Carica papaya Nutrition 0.000 claims abstract description 13
- 244000189799 Asimina triloba Species 0.000 claims abstract description 12
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 11
- 244000197580 Poria cocos Species 0.000 claims abstract description 11
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 11
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 10
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 9
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 9
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 9
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 9
- 229960003080 taurine Drugs 0.000 claims abstract description 8
- 230000001804 emulsifying effect Effects 0.000 claims abstract description 6
- 239000003925 fat Substances 0.000 claims abstract description 6
- 238000001694 spray drying Methods 0.000 claims abstract description 4
- 238000003809 water extraction Methods 0.000 claims abstract description 3
- 240000001949 Taraxacum officinale Species 0.000 claims abstract 3
- 235000019197 fats Nutrition 0.000 claims description 33
- 235000018102 proteins Nutrition 0.000 claims description 21
- 239000002253 acid Substances 0.000 claims description 19
- 235000001014 amino acid Nutrition 0.000 claims description 18
- 125000001931 aliphatic group Chemical group 0.000 claims description 15
- 239000000839 emulsion Substances 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 15
- 239000002994 raw material Substances 0.000 claims description 15
- 235000000346 sugar Nutrition 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 235000014633 carbohydrates Nutrition 0.000 claims description 13
- 239000000835 fiber Substances 0.000 claims description 9
- 241000206575 Chondrus crispus Species 0.000 claims description 8
- 235000010489 acacia gum Nutrition 0.000 claims description 8
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 108010010803 Gelatin Proteins 0.000 claims description 6
- 235000013373 food additive Nutrition 0.000 claims description 6
- 239000002778 food additive Substances 0.000 claims description 6
- 239000008273 gelatin Substances 0.000 claims description 6
- 229920000159 gelatin Polymers 0.000 claims description 6
- 235000019322 gelatine Nutrition 0.000 claims description 6
- 235000011852 gelatine desserts Nutrition 0.000 claims description 6
- 229920001285 xanthan gum Polymers 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 229920001817 Agar Polymers 0.000 claims description 4
- 108010011485 Aspartame Proteins 0.000 claims description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 4
- 229920002752 Konjac Polymers 0.000 claims description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 4
- 229930064664 L-arginine Natural products 0.000 claims description 4
- 235000014852 L-arginine Nutrition 0.000 claims description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 4
- 239000008272 agar Substances 0.000 claims description 4
- 235000010419 agar Nutrition 0.000 claims description 4
- 239000000605 aspartame Substances 0.000 claims description 4
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 4
- 235000010357 aspartame Nutrition 0.000 claims description 4
- 229960003438 aspartame Drugs 0.000 claims description 4
- 235000003132 food thickener Nutrition 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 235000013599 spices Nutrition 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 claims description 3
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 3
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 3
- 229920002581 Glucomannan Polymers 0.000 claims description 3
- 229920002907 Guar gum Polymers 0.000 claims description 3
- 229920000161 Locust bean gum Polymers 0.000 claims description 3
- 229940046240 glucomannan Drugs 0.000 claims description 3
- 239000000665 guar gum Substances 0.000 claims description 3
- 235000010417 guar gum Nutrition 0.000 claims description 3
- 229960002154 guar gum Drugs 0.000 claims description 3
- 239000000252 konjac Substances 0.000 claims description 3
- 235000010485 konjac Nutrition 0.000 claims description 3
- 235000010420 locust bean gum Nutrition 0.000 claims description 3
- 239000000711 locust bean gum Substances 0.000 claims description 3
- 239000001814 pectin Substances 0.000 claims description 3
- 235000010987 pectin Nutrition 0.000 claims description 3
- 229920001277 pectin Polymers 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 239000011812 mixed powder Substances 0.000 claims description 2
- 238000012163 sequencing technique Methods 0.000 claims description 2
- 239000011805 ball Substances 0.000 claims 1
- 239000002777 nucleoside Substances 0.000 claims 1
- 125000003835 nucleoside group Chemical group 0.000 claims 1
- 230000036039 immunity Effects 0.000 abstract description 9
- 230000002924 anti-infective effect Effects 0.000 abstract description 8
- 230000008859 change Effects 0.000 abstract description 5
- 230000002159 abnormal effect Effects 0.000 abstract description 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 abstract description 3
- 238000012545 processing Methods 0.000 abstract description 3
- 239000004475 Arginine Substances 0.000 abstract description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract description 2
- 230000001575 pathological effect Effects 0.000 abstract description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract 1
- 235000013350 formula milk Nutrition 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 241000699666 Mus <mouse, genus> Species 0.000 description 14
- -1 lard Substances 0.000 description 13
- 239000003921 oil Substances 0.000 description 12
- 235000019198 oils Nutrition 0.000 description 12
- 208000015181 infectious disease Diseases 0.000 description 11
- 230000006870 function Effects 0.000 description 10
- 229920002774 Maltodextrin Polymers 0.000 description 9
- 239000005913 Maltodextrin Substances 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 9
- 230000003110 anti-inflammatory effect Effects 0.000 description 9
- 229940035034 maltodextrin Drugs 0.000 description 9
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 235000010469 Glycine max Nutrition 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 8
- 241000245665 Taraxacum Species 0.000 description 8
- 239000005862 Whey Substances 0.000 description 8
- 108010046377 Whey Proteins Proteins 0.000 description 8
- 102000007544 Whey Proteins Human genes 0.000 description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 8
- 230000029663 wound healing Effects 0.000 description 8
- 244000068988 Glycine max Species 0.000 description 7
- 241000191967 Staphylococcus aureus Species 0.000 description 7
- 206010052428 Wound Diseases 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 241000251468 Actinopterygii Species 0.000 description 6
- 108010073771 Soybean Proteins Proteins 0.000 description 6
- 241000194017 Streptococcus Species 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 235000019688 fish Nutrition 0.000 description 6
- 238000003304 gavage Methods 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 231100000668 minimum lethal dose Toxicity 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 239000011435 rock Substances 0.000 description 6
- 235000019710 soybean protein Nutrition 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 229920001202 Inulin Polymers 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 108010038807 Oligopeptides Proteins 0.000 description 5
- 102000015636 Oligopeptides Human genes 0.000 description 5
- 235000004347 Perilla Nutrition 0.000 description 5
- 244000124853 Perilla frutescens Species 0.000 description 5
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 5
- 244000046052 Phaseolus vulgaris Species 0.000 description 5
- 235000011453 Vigna umbellata Nutrition 0.000 description 5
- 240000001417 Vigna umbellata Species 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 239000003240 coconut oil Substances 0.000 description 5
- 235000019864 coconut oil Nutrition 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 239000004519 grease Substances 0.000 description 5
- 230000002949 hemolytic effect Effects 0.000 description 5
- 230000036737 immune function Effects 0.000 description 5
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 5
- 229940029339 inulin Drugs 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 239000004006 olive oil Substances 0.000 description 5
- 235000008390 olive oil Nutrition 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000001681 protective effect Effects 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 235000015424 sodium Nutrition 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000003549 soybean oil Substances 0.000 description 5
- 235000012424 soybean oil Nutrition 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 102000004895 Lipoproteins Human genes 0.000 description 4
- 108090001030 Lipoproteins Proteins 0.000 description 4
- 240000003183 Manihot esculenta Species 0.000 description 4
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 235000013734 beta-carotene Nutrition 0.000 description 4
- 239000011648 beta-carotene Substances 0.000 description 4
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 4
- 229960002747 betacarotene Drugs 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 235000021277 colostrum Nutrition 0.000 description 4
- 210000003022 colostrum Anatomy 0.000 description 4
- 235000008504 concentrate Nutrition 0.000 description 4
- 239000011162 core material Substances 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 229960000304 folic acid Drugs 0.000 description 4
- 235000019152 folic acid Nutrition 0.000 description 4
- 239000011724 folic acid Substances 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 4
- 239000003094 microcapsule Substances 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 235000001968 nicotinic acid Nutrition 0.000 description 4
- 229960003512 nicotinic acid Drugs 0.000 description 4
- 239000011664 nicotinic acid Substances 0.000 description 4
- 229940055726 pantothenic acid Drugs 0.000 description 4
- 235000019161 pantothenic acid Nutrition 0.000 description 4
- 239000011713 pantothenic acid Substances 0.000 description 4
- 235000019477 peppermint oil Nutrition 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 239000011691 vitamin B1 Substances 0.000 description 4
- 239000011715 vitamin B12 Substances 0.000 description 4
- 239000011716 vitamin B2 Substances 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 239000011647 vitamin D3 Substances 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 229940045997 vitamin a Drugs 0.000 description 4
- 235000008939 whole milk Nutrition 0.000 description 4
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 238000012449 Kunming mouse Methods 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229960005069 calcium Drugs 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 229940091250 magnesium supplement Drugs 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 2
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 2
- 108090000526 Papain Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 206010058041 Wound sepsis Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000001989 choleretic effect Effects 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 231100000132 chronic toxicity testing Toxicity 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 229940100243 oleanolic acid Drugs 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 235000019834 papain Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010004053 Bacterial toxaemia Diseases 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 206010051548 Burn infection Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 240000005717 Dioscorea alata Species 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 241000208688 Eucommia Species 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 102100035695 Gamma-aminobutyric acid receptor-associated protein Human genes 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 241000175212 Herpesvirales Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 101001001372 Homo sapiens Gamma-aminobutyric acid receptor-associated protein Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 1
- 240000001740 Momordica dioica Species 0.000 description 1
- 235000018365 Momordica dioica Nutrition 0.000 description 1
- 244000179886 Moringa oleifera Species 0.000 description 1
- 235000011347 Moringa oleifera Nutrition 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 102000015094 Paraproteins Human genes 0.000 description 1
- 108010064255 Paraproteins Proteins 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001300674 Plukenetia volubilis Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000287420 Pyrus x nivalis Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 229920000294 Resistant starch Polymers 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 241000235546 Rhizopus stolonifer Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 206010061372 Streptococcal infection Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 235000010081 allicin Nutrition 0.000 description 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical group [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- MKJXYGKVIBWPFZ-CEOVSRFSSA-L calcium;(2s)-2-hydroxypropanoate Chemical compound [Ca+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O MKJXYGKVIBWPFZ-CEOVSRFSSA-L 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- GRWVQDDAKZFPFI-UHFFFAOYSA-H chromium(III) sulfate Chemical compound [Cr+3].[Cr+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRWVQDDAKZFPFI-UHFFFAOYSA-H 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 235000020243 first infant milk formula Nutrition 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000036732 histological change Effects 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000007233 immunological mechanism Effects 0.000 description 1
- 230000000091 immunopotentiator Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000007358 intestinal barrier function Effects 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical group [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- 239000011683 manganese gluconate Substances 0.000 description 1
- 235000014012 manganese gluconate Nutrition 0.000 description 1
- 229940072543 manganese gluconate Drugs 0.000 description 1
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 230000009854 mucosal lesion Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 235000016236 parenteral nutrition Nutrition 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Substances [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000021254 resistant starch Nutrition 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000007949 saponins Chemical group 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明涉及一种烧伤专用型临床营养配方，包括蛋白质和氨基酸、核苷酸、脂肪、碳水化合物、膳食纤维、常量元素、微量元素、维生素、膳食精华、药食同源成分、天然植物化合物和新资源食品；其中氨基酸包括L‑谷氨酰胺、L‑精氨酸、牛磺酸；药食同源成分包括薄荷、茯苓、木瓜、蒲公英、酸枣仁、金银花；其制备方法为：各组分均预先制成粉末，然后制成相应的剂型，其中药食同源成分进行水提浓缩、喷雾干燥制成粉末，维生素和脂肪通过微胶囊化处理制成粉末；或通过湿法工艺对各组分进行乳化均质、喷雾干燥制成粉末。与现有技术相比，本发明所述的营养配方能纠正烧伤患者的异常病理、生理改变，增强患者的免疫力和抗感染能力，全面维持机体的正常功能。
Description
技术领域
本发明涉及肠内营养制剂领域，具体涉及一种烧伤专用型临床营养配方及其制备方法。
背景技术
烧伤是热力引起皮肤或其它组织的损害，主要指皮肤或黏膜，严重者也可伤及皮下或黏膜下组织，如肌肉、骨、关节甚至内脏。面积大、深度多的严重烧伤，可引起全身一系列的生理紊乱，如神经、内分泌、呼吸、排泄系统；各主要脏器的功能与代谢以及免疫反应都发生变化，烧伤是一种全身性损害的创伤，在临床过程中，可能发生感染、毒血症败血症及其它严重并发症。
烧伤后患者由于组织严重毁损，以及受剧烈应激反应及各种神经内分泌因素的影响，机体在糖、蛋白质、脂肪、维生素、微量元素代谢方面都发生一系列变化。一方面组织分解加剧，蛋白质大量丢失，能量消耗增加，代谢率升高；另一方面机体恢复及创面修复时也需大量营养物质。正确的代谢营养支持及调理，有利于降低机体代谢消耗，维护脏器功能，增强免疫机制，预防和控制感染，促进创面愈合。
但目前针对烧伤患者的治疗手段一般为伤口外敷涂药剂、口服中药制剂、肠外营养剂(如静脉注射)。伤口外敷涂药剂和口服中药制剂仅用于伤口的消炎止痛、消除感染，促进创面愈合，其并不能为烧伤患者提供蛋白质、脂肪等全面的营养需求；肠外营养剂(如静脉注射)虽然可为烧伤患者提供一定的营养支持，但输液容量及营养物质输入量难以控制，且输液时间较长。
随着特殊营养食品的发展，根据烧伤患者的生理特点和营养需求，针对烧伤患者开发的特殊配方食品也日益增多，例如中国专利CN105901703A公开了一种用于烧伤患者的海洋生物型肠内营养制剂，其含有以下有效成分：蛋白质、脂肪、碳水化合物、复合维生素、复合矿物质、牛黄酸、胆碱等，其可为患者提供均衡营养，但并未提及烧伤患者的抗感染能力，且其有效成分并未添加药食同源成分和天然植物化合物，其对烧伤患者的营养需求及恢复时间均存在一定不足。
为此，研制既能提供烧伤患者所需的各种营养素，又能提高烧伤的免疫力、抗感染能力，进而提高治疗效果的肠内营养配方产品，具有重要价值和广阔的市场。
发明内容
本发明的目的在于克服现有技术中的缺陷，提供一种烧伤专用型临床营养配方及其制备方法，本发明制备的烧伤专用型临床营养配方为烧伤患者提供全面的营养支持，其含有烧伤患者所需的适宜能量和各种关键营养素，提供了完全的必需微量营养成分；通过添加含有多种功能活性成分的药食同源成分，调节机体功能提高抵抗力，提高抗感染能力，同时调理肠胃，促进各类营养物质的吸收，本发明所述的营养配方中各成分相辅相成，能有效改善烧伤患者的营养摄入不足，并调理机体功能，有利于烧伤患者的早日康复。
为实现上述目的，本发明采用如下技术方案：
一方面，本发明提供一种烧伤专用型临床营养配方，包括如下组分：蛋白质和氨基酸、核苷酸、脂肪、碳水化合物、膳食纤维、常量元素、微量元素、维生素、膳食精华、药食同源成分、天然植物化合物以及新资源食品；其中，所述氨基酸包括L-谷氨酰胺、L-精氨酸、牛磺酸；其中，所述药食同源成分包括薄荷、茯苓、木瓜、蒲公英、酸枣仁、金银花。
为了进一步优化上述技术方案，本发明所采取的技术措施还包括：
优选地，所述脂肪中n-6脂肪酸与n-3脂肪酸的比例为4:1～2。
优选地，所述烧伤专用型临床营养配方，还包括食品增稠剂和食品添加剂，所述食品增稠剂为瓜尔胶、黄原胶、槐豆胶、魔芋胶、果胶、卡拉胶、琼脂、明胶、阿拉伯胶中的至少一种，所述食品添加剂为阿斯巴甜、食用香精香料、红糖中的至少一种。
优选地，所述维生素为水溶性维生素和脂溶性维生素，所述脂溶性维生素的重量占维生素总重量的10％～40％。
优选地，所述膳食纤维为水溶性膳食纤维。
优选地，所述组分的重量份数为：蛋白质和氨基酸20～40份、核苷酸0～1份、脂肪10～20份、碳水化合物30～60份、膳食纤维2～8份、常量元素0.6～1.2份、微量元素0.05-0.2份、维生素0.1～0.3份、膳食精华0.2～0.5份、药食同源成分0.2～3份、天然植物化合物0.1-1份以及新资源食品0.01-0.2份。
优选地，所述药食同源成分中各组分的重量份数如下：薄荷0～1份、茯苓0～1份、木瓜0～1份、蒲公英0～1份、酸枣仁0～1份、金银花0～1份。
优选地，所述蛋白质选自乳清蛋白粉、大豆分离蛋白、全脂奶粉、全蛋粉、乳铁蛋白、牛初乳粉、蛋白肽中的至少一种；其中，所述蛋白肽选自大豆低聚肽、小麦蛋白肽、蚕蛹蛋白肽、海洋鱼低聚肽粉、可乐肽、氨基肽、卵白蛋白肽中的至少一种
优选地，所述氨基酸选自L-赖氨酸-L-谷氨酸、L-谷氨酸、L-精氨酸、L-色氨酸、L-谷氨酰胺、牛磺酸、L-缬氨酸、L-异亮氨酸、L-亮氨酸中的至少一种。
优选地，所述核苷酸为5'-单磷酸胞苷。
优选地，所述脂肪包括饱和脂肪酸、多不饱和脂肪酸、单不饱和脂肪酸、OPO结构脂、DHA、EPA、ARA、磷脂中的至少一种，更具体地说所述脂肪包括红花籽油、核桃油、花生油、大豆油、阿甘油、橄榄油、茶油、美藤果油、椰子油、紫苏油、深海鱼油、可可油、棕榈油、牛油、奶油、猪油、中链甘油三酯、卵磷脂、单双甘油脂肪酸酯。
优选地，所述碳水化合物包括果糖、冰糖、乳糖、麦芽糊精、木薯淀粉、抗性淀粉中的至少两种。
优选地，所述膳食纤维包含菊粉、魔芋粉、低聚半乳糖、低聚果糖、低聚异麦芽糖、大豆多糖、环糊精、抗性糊精、大豆纤维中的至少一种。
优选地，所述常量元素选自柠檬酸钙、L-乳酸钙、磷酸氢钙、葡萄糖酸钾、柠檬酸钠、葡萄糖酸镁、硫酸镁中的至少一种。
优选地，所述微量元素选自葡萄糖酸亚铁、碘化钾、葡萄糖酸锌、亚硒酸钠、葡萄糖酸铜、硫酸铬、葡萄糖酸锰和钼酸钠中的至少一种。
优选地，所述脂溶性维生素选自维生素A、β-胡萝卜素、维生素D3、维生素E、维生素K1中的至少一种。
优选地，所述水溶性维生素选自维生素B1、维生素B2、维生素B6、维生素B12、维生素C、泛酸、叶酸、烟酸、胆碱、肌醇、生物素中的至少一种。
优选地，所述膳食精华选自谷类、豆类、薯类、蔬菜类、菌藻类、坚果种子类、鱼虾类、禽畜肉类、水果类中的至少一种；其中所述谷类主要由大米粉、小米粉、黑米粉、薏米粉、玉米粉、小麦胚芽粉、燕麦粉、荞麦粉中的一种或至少两种组成，所述豆类主要由豌豆粉、绿豆粉、黑豆粉、红豆粉、大豆粉中的一种或至少两种组成，所述薯类主要由淮山粉组成，所述蔬菜粉主要由胡萝卜粉、白萝卜粉、南瓜粉、菠菜粉、番茄粉、西兰花粉、苦瓜粉、黄瓜粉中的一种或几种组成，所述菌藻类主要由香菇粉和银耳粉中的一种或几种，所述坚果种子类主要是莲子粉，所述鱼虾类主要是由三文鱼粉和鳕鱼粉中的一种或几种组成，所述禽畜肉类主要是由鸡肉粉、牛肉粉中的一种或几种组成，所述水果类主要由红枣粉、桂圆粉、苹果粉、樱桃粉、柑橘粉、雪梨粉中的一种或几种组成；所述膳食精华优选红豆粉。
优选地，所述天然植物化合物选自左旋肉碱、氨基葡萄糖、低聚果糖、叶黄素、番茄红素、白藜芦醇、大蒜素中的至少一种；所述天然植物化合物优选为左旋肉碱。
优选地，所述新资源食品选自初乳碱性蛋白、γ-氨基丁酸、壳寡糖、杜仲雄花、蚌肉多糖、植物甾醇、竹叶黄酮、酪蛋白磷酸肽、燕麦β-葡聚糖、酵母β-葡聚糖、辣木叶、低聚木糖中的至少一种；所述新资源食品优选为植物甾醇。
另一方面，本发明涉及一种上述烧伤专用型临床营养配方的制备方法，包括如下步骤：
步骤一、将预定重量份数的蛋白质和氨基酸、核苷酸、脂肪、碳水化合物、膳食纤维、常量元素、微量元素、维生素、药食同源成分、天然植物化合物以及新资源食品分别制备成粒径为150～250μm的粉末；
步骤二、将所述步骤一制备的粉末依次倒入锥形混合机中混合均匀；
步骤三、采用所述步骤一混合均匀的粉末制备成营养粉、营养乳剂、胶囊剂、片剂、丸剂或口服液中的至少一种；
其中，所述药食同源成分的原料进行粉碎、水提浓缩，并将浓缩液进行喷雾干燥制成药食同源成分粉末；
其中，所述维生素和脂肪分别通过微胶囊化处理制备成维生素粉末和脂肪粉末。
优选地，所述药食同源成分粉末的制备过程如下：采用粉碎机对预定重量份数的原料进行粉碎，将粉碎的原料置于容器中，加入重量为原料重量的3～8倍的水，进行浸泡3～4小时，然后对浸泡液进行煎煮30～60min，过滤去除原料，留取煎煮液，对煎煮液进行喷雾干燥制备药食同源成分粉末。
优选地，所述维生素的微胶囊化处理的具体步骤如下：1)将脂溶性维生素作为芯材，选用羧甲基纤维素钠、明胶、卡拉胶、黄原胶、阿拉伯胶、麦芽糊精、脂蛋白、玉米糖浆、大豆分离蛋白、全脂乳粉、膳食纤维、菊粉、乳清蛋白粉、低聚异麦芽糖、大豆纤维、乳糖、冰糖粉、乳化剂、稳定剂中的一种或多种作为壁材，高压均质乳化，喷雾瞬时干燥，筛分制备脂溶性维生素粉末；2)将水溶性维生素作为芯材，选用羧甲基纤维素钠、明胶、卡拉胶、黄原胶、阿拉伯胶、麦芽糊精、脂蛋白、玉米糖浆、大豆分离蛋白、全脂乳粉、膳食纤维、菊粉、乳清蛋白粉、低聚异麦芽糖、大豆纤维、乳糖、冰糖粉、乳化剂、稳定剂中的一种或多种作为壁材，混合均匀，喷雾瞬时干燥，筛分制备水溶性维生素粉末。
优选地，所述脂肪的微囊包埋技术的具体实施步骤如下：将脂肪、乳化剂、壁材与水混合溶解制备乳化液；将上述乳化液搅拌混合后，进行乳化均质处理，然后进行喷雾干燥，筛分制备粉末油脂，粉末油脂与传统油脂比较，其分散性、水溶性、乳化性、抗氧化性都有很大提高；其中，所述乳化剂选自甘油脂肪酸酯(甘油酯)、丙二醇脂肪酸酯(丙二醇酯)、山梨聚糖脂肪酸酯(山梨聚糖酸)、蔗糖脂肪酸酯(蔗糖酯)、卵磷脂中的一种或多种；所述壁材选自羧甲基纤维素钠、明胶、卡拉胶、黄原胶、阿拉伯胶、麦芽糊精、脂蛋白、玉米糖浆、大豆分离蛋白、全脂乳粉、膳食纤维、菊粉、乳清蛋白粉、低聚异麦芽糖、大豆纤维、乳糖、冰糖粉、乳化剂、稳定剂中的一种或多种。
本发明还提供一种上述烧伤专用型临床营养配方的制备方法，其为湿法工艺，包括如下步骤：
步骤1)准备含有预定重量份数的蛋白质和氨基酸、核苷酸、脂肪、碳水化合物、膳食纤维、常量元素、微量元素、维生素、药食同源成分、天然植物化合物以及新资源食品的原材料，按照原材料的物理性状，按照先后顺序依次添加，在添加的同时进行搅拌，制得原料的混合乳液；
步骤2)将步骤1)获得的混合乳液的温度保持在40-50℃，调整均质压力使其始终保持在10-18Mpa之间，对混合乳液进行乳化均质，然后将乳化液放置蒸发器中，以预设的技术参数进行浓缩，并在85-88℃下进行杀菌，获得浓缩液；
步骤3)将步骤2)获得的浓缩液进行喷雾干燥，过60～80目筛，制备成粉末；采用上述粉末制备成营养粉、营养乳剂、胶囊剂、片剂、丸剂或口服液中的至少一种。
本发明采用具有增强免疫力、提高抗感染、调理脾胃的药食同源成分，其包括薄荷、茯苓、木瓜、蒲公英、酸枣仁、金银花。
薄荷中的有效成分薄荷油、薄荷醇可抑制核盘菌、匍茎根霉菌、毛霉菌等真菌的生长和繁殖；薄荷油对单纯疱疹病毒的两种亚型(HSV21和HSV22)均显示较强的抑制作用；同时薄荷油有明显的利胆作用，并能轻度增加胆汁中胆汁酸的排出量；且薄荷油对角叉菜胶致大鼠足肿胀有一定的抑制作用，具有消炎镇痛的功效。
茯苓能增强机体免疫功能，其具有抗胸腺萎缩、抗脾脏增大和抑瘤生长的作用；茯苓多糖有明显的抗肿瘤作用；有利尿作用，能增加尿中钾、钠、氯等电解质的排出；有镇静及保护肝脏、抑制溃疡的发生、降血糖、抗放射等作用；茯苓还具有抗菌、抗炎、抗病毒作用，其对金黄色葡萄球菌、白色葡萄球菌、甲型/乙型链球菌等均有抑制作用。
木瓜中含有多种有益成分，包括木瓜多糖、木瓜蛋白酶、齐墩果酸、甾醇类化合物等；木瓜多糖具有抗凝血、抑感染、御放射、抗肿瘤、抗炎、抗病毒、抗衰老等作用，是理想的免疫增强剂；木瓜蛋白酶能够分解蛋白质，有辅助治疗肠胃炎、消化不良，木瓜含有多种水溶性维生素，如富含维生素C，有助于修复机体组织，消除损害机体细胞的有毒物质，增强人体抗病能力；齐墩果酸以单体或皂甙形式存在，具有消炎、增强免疫力、降转氨酶、纠正体内异常蛋白代谢、防止肝硬化；甾醇类化合物，对人体具有较强的抗炎作用，可促进伤口愈合,使肌肉增生、增强毛细血管循环。
蒲公英具有抗病原微生物作用，其对金黄色葡萄球菌耐药菌株、溶血性链球菌有较强的杀菌作用，对肺炎双球菌、脑膜炎球菌、白喉杆菌、绿脓杆菌、变形杆菌、痢疾杆菌、伤寒杆菌等及卡他球菌亦有一定的杀菌作用；具有保肝、利胆作用，其对四氯化碳引起的谷丙转氨酶升高有明显抑制作用，能显著缓解四氯化碳性肝损伤引起的组织学改变；具有抗胃溃疡作用，其对胃黏膜损伤有显著保护作用；具有提高免疫功能的作用，可提高人外周血淋巴细胞母细胞转化率，蒲公英多糖能显著增强艾氏癌及MM46肿瘤细胞抗原所致小鼠脚垫迟发型超敏反应强度。
酸枣仁中的有效成分皂甙类和黄酮类化合物具有显著的镇静和催眠作用，酸枣仁还具有明显的抗惊厥作用，可明显抑制青霉素钠对神经元细胞的兴奋作用，降低谷氨酸水平的升高，且有抗癫痫作用；酸枣仁苷类还表现出对心血管系统有明显的保护作用，具有抗心机缺血作用；酸枣仁水提取液具有明显的抗炎作用，能抑制小鼠腹腔、背部皮肤及耳廓毛细血管通透性，对大鼠后足蛋清性肿胀及大鼠腋下植入纸片产生的肉芽肿均有抑制作用。
金银花对多种致病菌如金黄色葡萄球菌、溶血性链球菌、肺炎球菌、脑膜炎双球菌、绿脓杆菌等有抑菌和杀菌作用，对流感病毒、孤儿病毒、疱疹病毒、钩端螺旋体均有抑制作用；金银花具有清热解毒、疏散风热的作用，可治疗暑热症、泻痢、流感、疮疖肿毒、急慢性扁桃体炎、牙周炎等病。
本发明还采用包括L-谷氨酰胺、L-精氨酸、牛磺酸的氨基酸以及核苷酸。谷氨酰胺能修复小肠上皮、维持肠屏障功能，防止肠道细菌和毒素移位以及减少肠源性感染。精氨酸能强化精氨酸的营养支持可有效促进细胞免疫功能，有效提高免疫力，对抗癌细胞及预防病毒感染。核苷酸可纠正烧伤病人的细胞免疫功能紊乱，降低创面脓毒症发生率，减轻烧伤感染，提高烧伤患者免疫功能，从细胞水平纠正烧伤患者免疫功能抑制，使其重建免疫功能。
本发明中采用脂肪中n-6脂肪酸与n-3脂肪酸的比例为4:1～2，n-3脂肪酸可调节免疫性的炎症性反应，尽可能地改善脓毒病或多器官衰竭。
本发明中采用新资源食品植物甾醇，其对人体具有较强的抗炎作用，具有能够抑制人体对胆固醇的吸收、促进胆固醇的降解代谢、抑制胆固醇的生化合成等作用；其可促进伤口愈合，使肌肉增生、增强毛细血管循环等功能。
与现有技术相比，本发明具有以下的优异效果：
(1)本发明将现代营养学研究成果与传统中医理论相结合，通过各种组分的有机组合，将各种功能进行融合，并通过有效成分之间的协同作用，增强作用效果。按本发明配方制作的食品不仅可以补充烧伤患者所需营养，还能利用中草药成分促进机体状况改善。
(2)本发明添加具有抗感染、增强免疫、调理消化功效的药食同源成分，添加提高免疫力、降低创面脓毒症发生率、减轻烧伤感染的氨基酸和核苷酸，添加能够调节免疫性的炎症性反应的n-3脂肪酸，添加具有抗炎、促进伤口愈合的植物甾醇，其各组分相辅相成，疗效确切，能纠正烧伤患者的异常病理、生理改变，维持机体细胞和组织、器官的正常结构和功能，增强患者免疫、提高治疗效果，以早日康复。
(3)本发明添加了膳食纤维，其能改善危重症患者的营养状态，纠正机体的负氮平衡；改善危重症患者的免疫功能，减少并发症的发生；有效降低危重症患者的血糖，减少高血糖的危害，减轻患者的应激反应；促进胃肠道蠕动，改善胃肠功能，减轻过度的炎症反应，防止肠源性感染的发生。
(4)本发明采用微囊包埋技术制备维生素，将维生素被包埋于壁材中，可防止维生素遭受常量元素、微量元素的破坏，延长维生素的保存时间；本发明采用微囊包埋技术制备油脂粉末，使得油脂粉末具有较好的流动性，易于与其他粉状组分混合均匀；且采用微囊包埋技术后，油脂被包埋于壁材中，从而避免了与空气的接触以增强抗氧化性，从而可发挥保健型油脂的最大功效。
(5)本发明所述的烧伤专用型临床营养配方的原料在制备过程中均预先制备成150～250μm的粉末，这使得在制备成品时，各营养组分能够混合均匀，保证单位体积中的各营养组分的含量相同，同时在制备液体类制剂时，各营养组分能充分分散并完全溶解至溶剂中，防止液体中出现固体沉淀，有效保证了成品产品的功效。
具体实施方式
本发明提供一种针对烧伤专用型临床营养配方专用型临床营养配方，包括如下重量份数的组分：蛋白质和氨基酸20～40份、核苷酸0～1份、脂肪10～20份、碳水化合物30～60份、膳食纤维2～8份、常量元素0.6～1.2份、微量元素0.05-0.2份、维生素0.1～0.3份、膳食精华0.2～0.5份、药食同源成分0.2～3份、天然植物化合物0.1-1份以及新资源食品0.01-0.2份；其中，所述维生素为水溶性维生素和脂溶性维生素，所述脂溶性维生素的重量占维生素总重量的10％～40％；其中，所述膳食纤维为水溶性膳食纤维，所述脂肪中n-6脂肪酸与n-3脂肪酸的比例为4:1～2。
下面结合实施例，对本发明的具体实施方式作进一步描述。以下实施例仅用于更加清楚地说明本实用新型的技术方案，而不能以此来限制本发明的保护范围。
实施例1
本发明所述的烧伤专用型临床营养配方包括乳清蛋白粉10.4g、大豆分离蛋白5.2g、全脂奶粉12g、全蛋粉0.33g、牛初乳0.16g、牛磺酸0.12g、海洋鱼低聚肽0.1g；5'-单磷酸胞苷0.1g；橄榄油2.77g、大豆油4.48g、椰子油2.77g、紫苏油0.64g、中链甘油三酯0.21g；麦芽糊精35g、冰糖6.2g、木薯淀粉7.49g；膳食纤维3.5g；常量元素中钙0.44g、磷0.23g、钾0.08g、钠0.14g、镁0.19g；微量元素中铁0.015g、碘0.00014g、锌0.13g；维生素A 0.0005g、β-胡萝卜素0.000057g、维生素D3 0.000002g、维生素E 0.01g；维生素B1 0.001g、维生素B20.001g、维生素B6 0.001g、维生素B12 0.000003g、维生素C 0.188g、泛酸0.005g、叶酸0.000165g、烟酸0.0161g；红豆粉0.33g；薄荷0.05g、茯苓0.05g、木瓜0.05g、蒲公英0.05g、酸枣仁0.05g、金银花0.05g；天然植物化合物中左旋肉碱0.63g，；新资源食品中植物甾醇0.05g；其中，所述膳食纤维都为水溶性膳食纤维；所述脂溶性维生素的重量占维生素总重量的10％～40％；所述脂肪中n-6脂肪酸与n-3脂肪酸的比例为4:1。
实施例2
本发明所述的烧伤专用型临床营养配方包括乳清蛋白粉10.4g、大豆分离蛋白5.2g、全脂奶粉12g、全蛋粉0.33g、牛初乳0.16g、牛磺酸0.12g、海洋鱼低聚肽0.1g；橄榄油2.77g、大豆油4.48g、椰子油2.77g、紫苏油0.64g、中链甘油三酯0.21g；麦芽糊精35g、冰糖6.2g、木薯淀粉7.49g；膳食纤维3.5g；常量元素中钙0.44g、磷0.23g、钾0.08g、钠0.14g、镁0.19g；微量元素中铁0.015g、碘0.00014g、锌0.13g；维生素A 0.0005g、β-胡萝卜素0.000057g、维生素D3 0.000002g、维生素E 0.01g；维生素B1 0.001g、维生素B2 0.001g、维生素B6 0.001g、维生素B12 0.000003g、维生素C 0.188g、泛酸0.005g、叶酸0.000165g、烟酸0.0161g；红豆粉0.33g；薄荷0.17g、茯苓0.17g、木瓜0.17g、蒲公英0.17g、酸枣仁0.17g、金银花0.17g；天然植物化合物中左旋肉碱0.63g，；新资源食品中植物甾醇0.1g；其中，所述膳食纤维都为水溶性膳食纤维；所述脂溶性维生素的重量占维生素总重量的10％～40％；所述脂肪中n-6脂肪酸与n-3脂肪酸的比例为4:1。
实施例3
本发明所述的烧伤专用型临床营养配方包括乳清蛋白粉10.4g、大豆分离蛋白5.2g、全脂奶粉12g、全蛋粉0.33g、牛初乳0.16g、牛磺酸0.12g、海洋鱼低聚肽0.1g；橄榄油2.77g、大豆油4.48g、椰子油2.77g、紫苏油0.64g、中链甘油三酯0.21g；麦芽糊精35g、冰糖6.2g、木薯淀粉7.49g；膳食纤维3.5g；常量元素中钙0.44g、磷0.23g、钾0.08g、钠0.14g、镁0.19g；微量元素中铁0.015g、碘0.00014g、锌0.13g；维生素A 0.0005g、β-胡萝卜素0.000057g、维生素D3 0.000002g、维生素E 0.01g；维生素B1 0.001g、维生素B2 0.001g、维生素B6 0.001g、维生素B12 0.000003g、维生素C 0.188g、泛酸0.005g、叶酸0.000165g、烟酸0.0161g；红豆粉0.33g；薄荷0.17g、茯苓0.17g、木瓜0.17g、蒲公英0.17g、酸枣仁0.17g、金银花0.17g；天然植物化合物中左旋肉碱0.63g，；新资源食品中植物甾醇0.05g；其中，所述膳食纤维都为水溶性膳食纤维；所述脂溶性维生素的重量占维生素总重量的10％～40％；所述脂肪中n-6脂肪酸与n-3脂肪酸的比例为4:1。
实施例4
含有实施例1-实施例3的烧伤专用型临床营养配方的制备方法如下：
1)制备粉末油脂(粉末脂肪)：
a)制备壁材水溶液：取麦芽糊精8克、大豆分离蛋白4克、全脂乳粉11克、膳食纤维2克(抗性糊精)、菊粉0.5克、乳清蛋白粉5克、低聚异麦芽糖0.5克、大豆纤维1克、阿拉伯胶0.2克、乳糖0.5克、冰糖粉2克、水50毫升搅拌均匀(有条件边加热边搅拌至60℃，保持30分钟后冷却至室温)。
b)将单甘酯取0.1克(总固形物浓度为0.2％)均匀溶于10.2毫升油脂中(橄榄油2.6毫升、大豆油4.2毫升、椰子油2.6毫升、紫苏油0.6毫升、中链甘油三酯0.2毫升)。
c)将吐温80取0.1克(总固形物浓度为0.2％)均匀溶于壁材水溶液中。
d)将添加过乳化剂单甘酯的混合植物油脂与添加过乳化剂吐温80的壁材水溶液充分混合。
e)添加稳定剂琼脂取0.1克(总固形物浓度为0.2％)进混合溶液后，用水定容至200毫升(总固形物浓度为25％)，20000r/min下高速分散2分钟。
f)均质压力为25MPa，均质3次(每次5分钟)，制得均质乳状液。
g)将制得的乳状液进行喷雾干燥，进风温度为195℃，出风温度为80℃。收集粉末油脂(粉末脂肪)。
2)制备药食同源成分粉末：采用粉碎机对预定重量份数的原料进行粉碎，将粉碎的原料置于容器中，加入重量为原料重量的3～8倍的水，进行浸泡3～4小时，然后对浸泡液进行煎煮30～60min，过滤去除原料，留取煎煮液，对煎煮液进行喷雾干燥，以60～80目筛分制备药食同源成分粉末；
3)制备维生素粉末：将预定重量份数的脂溶性维生素作为芯材，选用卡拉胶、阿拉伯胶作为壁材，在高压下进行2次乳化均质处理，乳化均质时间为10～15min，然后进行喷雾瞬时干燥，以60～80目筛分制备脂溶性维生素粉末；将预定重量份数的水溶性维生素作为芯材，选用麦芽糊精、脂蛋白作为壁材，混合均匀，喷雾瞬时干燥，以60～80目筛分制备水溶性维生素粉末；
4)将预定重量的蛋白质和氨基酸、核苷酸、碳水化合物、膳食纤维、常量元素、微量元素、膳食精华、天然植物化合物以及新资源食品分别制备成粒径为150～250μm的粉末；
5)将步骤1)～步骤4)所制得的粉末依次加入锥形混合机或其他形式的混合机混合均匀制得配方混合物，经过杀菌处理后，备用；
6)根据常规技术手段将步骤5)中的配方混合物制备成营养粉、营养乳剂、胶囊剂、片剂、丸剂或口服液中的至少一种。
在步骤6)中，可选择性地增加适量的食品增稠剂和食品添加剂。所述食品增稠剂为瓜尔胶、黄原胶、槐豆胶、魔芋胶、果胶、卡拉胶、琼脂、明胶、阿拉伯胶中的至少一种，所述食品添加剂为阿斯巴甜、食用香精香料、红糖中的至少一种；更优选卡拉胶、阿拉伯胶、瓜尔胶、阿斯巴甜、食用香精香料。
上述操作步骤均需在惰性气体的保护下进行，比如氮气、氩气、氦气等，以防止产生粉末爆炸的危险。
实施例5
1)本发明提供的专用型临床营养配方对小鼠急性毒性和慢性毒性试验；
小鼠急性毒性试验：釆用本发明实施例1～3制备的营养粉喂饲小鼠，连续观察14天，试验期间未见死亡和异常毒性反应，试验结束后，处死小鼠，解剖试验小鼠，观察肝、肾、脾、胃、心、肺和肠，均未见异常改变。按急性毒性标准，该样品属于无毒级。
小鼠慢性毒性试验：釆用本发明实施例1～3制备的营养粉喂饲小鼠，连续饲喂90天，试验结果饲喂本发明实施例1～3制备的营养粉的小鼠行为活动正常，摄食饮水正常，体重正常增加，血液生化指标和血液学均在正常范围内波动，尿常规和骨髓指标均在正常范围内波动，组织脏器未见异常，整体而言未见毒理反应，由上述实验可知，本发明制备的配方产品是安全、无毒的。
2)本发明提供的专用型临床营养配方对小鼠烧伤后抗感染的影响；
取本发明实施例1～3制备的营养粉进行试验，同时设对比例1、对比例2、空白组和对照组，对比例1采用实施例2的营养配方中删除氨基酸和核苷酸制备的营养粉，对比例2采用实施例2的营养配方中删除药食同源成分制备的营养粉。
取昆明小鼠32只，雌雄各半，随机分成2组，每组16只。将金黄色葡萄球菌(CMCC26112)、乙型溶血性链球菌(CMCC32210)接种在牛肉膏汤液体培养基内，置37℃培养箱18h。用生理盐水稀释为10-1～10-8浓度的菌液。将各浓度的金黄色葡萄球菌、乙型溶血性链球菌、肺炎双球菌、流感嗜血杆菌按照0.5ml/只剂量，分别腹腔注射感染小鼠。观察小鼠在5d内的死亡状况，测试出试验菌株引起动物100％死亡的最小致死量(MLD)。
表1实验用菌株对小鼠的最小致死量(MLD)
分别取昆明小鼠140只，雌雄各半，随机分成14组，每组10只，进行每个菌种的感染所致小鼠死亡的保护实验。实施例1～实施例3、对比例1～对比例2组按照剂量1000mg/kg/day灌胃，空白组用等体积生理盐水灌胃，对照组用0.4g/kg阿莫西林灌胃。连续3d后，各组于第4天开始，按照最小致死量(MLD)腹腔注射不同菌株。按照先前剂量，再继续给各组小鼠灌胃3d。观察记录感染后7d内各组小鼠的死亡数，计算死亡率。
表2各配方对金黄色葡萄球菌感染所致小鼠死亡的保护作用
表3各配方对乙型溶血性链球菌感染所致小鼠死亡的保护作用
实验表明实施例1～实施例3、对比例1～对比例2组对金黄色葡萄球菌、乙型溶血性链球菌感染所致小鼠死亡有不同程度的保护作用。
3)本发明提供的专用型临床营养配方对小鼠烧伤后愈合情况的影响；
取本发明实施例1～3制备的营养粉进行试验，同时设对比例1、对比例2、空白对照组，对比例1采用实施例2的营养配方中删除氨基酸和核苷酸制备的营养粉，对比例2采用实施例2的营养配方中删除药食同源成分制备的营养粉，空白对照组灌胃正常饲料。
分别取昆明小鼠140只，雌雄各半，随机分成7组，每组20只，对每一小鼠的同一部位进行轻微烧伤，烧伤面积为3×3cm，然后对每一小鼠进行正常治疗。在正常治疗外，实施例1～3、对比例1～2的营养粉均按照剂量1000mg/kg/day灌胃，持续服用至伤口愈合，空白对照组喂食正常饲料至伤口愈合。对烧伤小鼠来说，评判药效的标准有愈合时间、伤口的感染情况，其实验结果如表3所示。
表3伤口愈合的实验结果
由上表可知，本发明添加的药食同源组分和膳食纤维，与蛋白质、碳水化合物等营养元素之间发生了很好的协同作用，其对烧伤患者具有辅助治疗效果；另外，通过与对比例1和对比例2进行比较发现，氨基酸、核苷酸和药食同源成分对于改善烧伤患者抗感染和伤口愈合是必不可少的，其与本发明其他组分相辅相成，充分发挥各自的功效，才能取得优异的效果。
以上对本发明的具体实施例进行了详细描述，但其只作为范例，本发明并不限制于以上描述的具体实施例。对于本领域技术人员而言，任何对该实用进行的等同修改和替代也都在本发明的范畴之中。因此，在不脱离本发明的精神和范围下所作的均等变换和修改，都应涵盖在本发明的范围内。
Claims (9)
1.一种烧伤专用型临床营养配方，其特征在于，包括如下组分：蛋白质和氨基酸、核苷酸、脂肪、碳水化合物、膳食纤维、常量元素、微量元素、维生素、膳食精华、药食同源成分、天然植物化合物以及新资源食品；
其中，所述氨基酸包括L-谷氨酰胺、L-精氨酸、牛磺酸；
其中，所述药食同源成分包括薄荷、茯苓、木瓜、蒲公英、酸枣仁、金银花。
2.根据权利要求1所述的一种烧伤专用型临床营养配方，其特征在于，还包括食品增稠剂和食品添加剂，所述食品增稠剂为瓜尔胶、黄原胶、槐豆胶、魔芋胶、果胶、卡拉胶、琼脂、明胶、阿拉伯胶中的至少一种，所述食品添加剂为阿斯巴甜、食用香精香料、红糖中的至少一种。
3.根据权利要求1所述的一种烧伤专用型临床营养配方，其特征在于，所述脂肪中n-6脂肪酸与n-3脂肪酸的比例为4:1～2。
4.根据权利要求1所述的一种烧伤专用型临床营养配方，其特征在于，所述维生素为水溶性维生素和脂溶性维生素，所述脂溶性维生素的重量占维生素总重量的10％～40％。
5.根据权利要求1所述的一种烧伤专用型临床营养配方，其特征在于，所述膳食纤维为水溶性膳食纤维。
6.根据权利要求1所述的一种烧伤专用型临床营养配方，其特征在于，所述组分的重量份数为：蛋白质和氨基酸20～40份、核苷酸0～1份、脂肪10～20份、碳水化合物30～60份、膳食纤维2～8份、常量元素0.6～1.2份、微量元素0.05-0.2份、维生素0.1～0.3份、膳食精华0.2～0.5份、药食同源成分0.2～3份、天然植物化合物0.1-1份以及新资源食品0.01-0.2份。
7.根据权利要求6所述的一种烧伤专用型临床营养配方，其特征在于，所述药食同源成分中各组分的重量份数如下：薄荷0～1份、茯苓0～1份、木瓜0～1份、蒲公英0～1份、酸枣仁0～1份、金银花0～1份。
8.一种如权利要求1～7中任一项所述的烧伤专用型临床营养配方的制备方法，其特征在于，包括如下步骤：
步骤一、将预定重量份数的蛋白质和氨基酸、核苷酸、脂肪、碳水化合物、膳食纤维、常量元素、微量元素、维生素、药食同源成分、天然植物化合物以及新资源食品分别制备成粒径为150～250μm的粉末；
步骤二、将所述步骤一制备的粉末依次倒入锥形混合机中混合均匀；
步骤三、采用所述步骤二中混合均匀的粉末制备成营养粉、营养乳剂、胶囊剂、片剂、丸剂或口服液中的至少一种；
其中，所述药食同源成分的原料进行粉碎、水提浓缩，并将浓缩液进行喷雾干燥制成药食同源成分粉末；
其中，所述维生素和脂肪分别通过微胶囊化处理制备成维生素粉末和脂肪粉末。
9.一种如权利要求1～7中任一项所述的烧伤专用型临床营养配方的制备方法，其特征在于，包括如下步骤：
步骤1)准备含有预定重量份数的蛋白质和氨基酸、核苷酸、脂肪、碳水化合物、膳食纤维、常量元素、微量元素、维生素、药食同源成分、天然植物化合物以及新资源食品的原材料，按照原材料的物理性状，按照先后顺序依次添加，在添加的同时进行搅拌，制得原料的混合乳液；
步骤2)将步骤1)获得的混合乳液进行乳化均质、浓缩杀菌，获得浓缩液；
步骤3)将步骤2)获得的浓缩液进行喷雾干燥，过筛，制备成粉末，并将上述粉末制备成营养粉、营养乳剂、胶囊剂、片剂、丸剂或口服液中的至少一种。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710197736.6A CN106858595A (zh) | 2017-03-29 | 2017-03-29 | 一种烧伤专用型临床营养配方及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710197736.6A CN106858595A (zh) | 2017-03-29 | 2017-03-29 | 一种烧伤专用型临床营养配方及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106858595A true CN106858595A (zh) | 2017-06-20 |
Family
ID=59159614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710197736.6A Pending CN106858595A (zh) | 2017-03-29 | 2017-03-29 | 一种烧伤专用型临床营养配方及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106858595A (zh) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107242550A (zh) * | 2017-06-29 | 2017-10-13 | 上海复旦奥医医学科技有限公司 | 一种男性不育专用型临床营养配方及其制备方法 |
| CN107319524A (zh) * | 2017-06-29 | 2017-11-07 | 上海复旦奥医医学科技有限公司 | 一种肾病专用型临床营养配方及其制备方法 |
| CN107440102A (zh) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | 一种更年期女性专用型临床营养配方及其制备方法 |
| CN107440121A (zh) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | 一种儿童单纯性肥胖专用型临床营养配方及其制备方法 |
| CN107616490A (zh) * | 2017-08-23 | 2018-01-23 | 上海奥医生物医药科技有限公司 | 一种儿童术后专用型临床营养配方及其制备方法 |
| CN110038131A (zh) * | 2019-04-25 | 2019-07-23 | 河北康睿达脂质有限公司 | 一种烧创伤皮肤细胞修复的结构脂质组合物及其应用 |
| CN114601172A (zh) * | 2022-03-10 | 2022-06-10 | 山东若尧特医食品有限公司 | 一种谷氨酰胺组合物特殊医学用途配方食品及其制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104286849A (zh) * | 2014-09-26 | 2015-01-21 | 上海励成营养产品科技股份有限公司 | 一种糖尿病专用型肠内营养多聚合剂 |
| CN105901703A (zh) * | 2016-04-19 | 2016-08-31 | 上海海洋大学 | 一种用于烧伤患者的海洋生物型肠内营养制剂 |
| CN106490605A (zh) * | 2016-12-23 | 2017-03-15 | 上海奥医生物医药科技有限公司 | 一种妊娠高血压专用型临床营养配方及其制备方法 |
-
2017
- 2017-03-29 CN CN201710197736.6A patent/CN106858595A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104286849A (zh) * | 2014-09-26 | 2015-01-21 | 上海励成营养产品科技股份有限公司 | 一种糖尿病专用型肠内营养多聚合剂 |
| CN105901703A (zh) * | 2016-04-19 | 2016-08-31 | 上海海洋大学 | 一种用于烧伤患者的海洋生物型肠内营养制剂 |
| CN106490605A (zh) * | 2016-12-23 | 2017-03-15 | 上海奥医生物医药科技有限公司 | 一种妊娠高血压专用型临床营养配方及其制备方法 |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107242550A (zh) * | 2017-06-29 | 2017-10-13 | 上海复旦奥医医学科技有限公司 | 一种男性不育专用型临床营养配方及其制备方法 |
| CN107319524A (zh) * | 2017-06-29 | 2017-11-07 | 上海复旦奥医医学科技有限公司 | 一种肾病专用型临床营养配方及其制备方法 |
| CN107440102A (zh) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | 一种更年期女性专用型临床营养配方及其制备方法 |
| CN107440121A (zh) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | 一种儿童单纯性肥胖专用型临床营养配方及其制备方法 |
| CN107616490A (zh) * | 2017-08-23 | 2018-01-23 | 上海奥医生物医药科技有限公司 | 一种儿童术后专用型临床营养配方及其制备方法 |
| CN110038131A (zh) * | 2019-04-25 | 2019-07-23 | 河北康睿达脂质有限公司 | 一种烧创伤皮肤细胞修复的结构脂质组合物及其应用 |
| CN110038131B (zh) * | 2019-04-25 | 2021-04-30 | 河北康睿达脂质有限公司 | 一种烧创伤皮肤细胞修复的结构脂质组合物及其应用 |
| CN114601172A (zh) * | 2022-03-10 | 2022-06-10 | 山东若尧特医食品有限公司 | 一种谷氨酰胺组合物特殊医学用途配方食品及其制备方法 |
| CN114601172B (zh) * | 2022-03-10 | 2024-03-19 | 山东若尧特医食品有限公司 | 一种谷氨酰胺组合物特殊医学用途配方食品及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106858620A (zh) | 一种贫血专用型临床营养配方及其制备方法 | |
| CN106858595A (zh) | 一种烧伤专用型临床营养配方及其制备方法 | |
| CN107319525A (zh) | 一种减肥减脂专用型临床营养配方及其制备方法 | |
| CN106962912A (zh) | 一种肝病专用型临床营养配方及其制备方法 | |
| CN101822383B (zh) | 一种适用于肿瘤患者的功能性营养代餐食品及其制备方法 | |
| CN106616615A (zh) | 一种肿瘤专用型临床营养配方及其制备方法 | |
| CN109123643A (zh) | 一种谷物代餐球的制备方法 | |
| CN106983136A (zh) | 一种产褥期调理专用型临床营养配方及其制备方法 | |
| CN106942748A (zh) | 一种女性不孕专用型临床营养配方及其制备方法 | |
| CN107319524A (zh) | 一种肾病专用型临床营养配方及其制备方法 | |
| CN107616490A (zh) | 一种儿童术后专用型临床营养配方及其制备方法 | |
| CN108013454A (zh) | 妇科炎症专用型临床营养配方及其制备方法 | |
| CN107440103A (zh) | 一种呼吸系统疾病专用型临床营养配方及其制备方法 | |
| CN108719984B (zh) | 一种针对痛风人群的代餐营养棒及其制备方法 | |
| CN104605353A (zh) | 适用于手术后肿瘤患者食用的配方食品及其制备方法 | |
| CN107440102A (zh) | 一种更年期女性专用型临床营养配方及其制备方法 | |
| CN106578093A (zh) | 一种创伤、感染、手术及其它应激状态专用型临床营养配方及其制备方法 | |
| CN103355544A (zh) | 一种哺乳期母猪饲料 | |
| CN108703365A (zh) | 蛋白质过敏专用型临床营养配方及其制备方法 | |
| CN104304679A (zh) | 一种复合维生素c、e免疫多糖微乳液制剂及其制备方法和应用 | |
| CN104222638A (zh) | 一种用于防治鲤鱼鳃霉病的功能性饲料及其制备方法 | |
| CN107373672A (zh) | 一种月经不调女性专用型临床营养配方及其制备方法 | |
| CN106418501A (zh) | 一种具有减肥功能的保健食品 | |
| CN105918387A (zh) | 一种适用中老年保健食品及制备方法 | |
| KR102430901B1 (ko) | 식용곤충을 배지로 이용하여 재배한 밀리타리스 동충하초 건조 분말이 함유된 반려동물용 영양간식 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170620 |
|
| RJ01 | Rejection of invention patent application after publication |